Susquehanna Fundamental Investments LLC Takes $1.07 Million Position in The Cigna Group (NYSE:CI)

Susquehanna Fundamental Investments LLC bought a new stake in shares of The Cigna Group (NYSE:CI - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 3,866 shares of the health services provider's stock, valued at approximately $1,068,000.

A number of other hedge funds have also made changes to their positions in the stock. Sterling Financial Group Inc. acquired a new position in shares of The Cigna Group in the 4th quarter worth approximately $4,367,000. Principal Financial Group Inc. raised its holdings in shares of The Cigna Group by 3.6% during the third quarter. Principal Financial Group Inc. now owns 323,911 shares of the health services provider's stock worth $112,216,000 after purchasing an additional 11,228 shares during the period. Deroy & Devereaux Private Investment Counsel Inc. lifted its position in shares of The Cigna Group by 1.1% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 75,837 shares of the health services provider's stock worth $20,942,000 after buying an additional 858 shares during the last quarter. Valley Wealth Managers Inc. boosted its holdings in shares of The Cigna Group by 2.8% in the 4th quarter. Valley Wealth Managers Inc. now owns 56,933 shares of the health services provider's stock valued at $15,721,000 after buying an additional 1,548 shares during the period. Finally, KBC Group NV boosted its stake in The Cigna Group by 1.5% in the fourth quarter. KBC Group NV now owns 550,638 shares of the health services provider's stock valued at $152,053,000 after acquiring an additional 8,077 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Stock Up 0.3 %

Shares of CI stock traded up $1.13 on Tuesday, hitting $334.14. The company's stock had a trading volume of 1,096,167 shares, compared to its average volume of 1,808,779. The stock has a market capitalization of $91.45 billion, a price-to-earnings ratio of 27.29, a P/E/G ratio of 0.98 and a beta of 0.47. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The firm's fifty day moving average price is $323.77 and its 200-day moving average price is $309.57. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.35 by $0.39. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The business had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. During the same period last year, the business posted $6.47 EPS. The Cigna Group's revenue was up 14.4% compared to the same quarter last year. Research analysts anticipate that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be given a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 1.81%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group's dividend payout ratio (DPR) is presently 49.35%.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the transaction, the chief executive officer now directly owns 127,767 shares in the company, valued at $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Noelle K. Eder sold 9,944 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the sale, the insider now directly owns 13,406 shares of the company's stock, valued at approximately $4,289,920. The trade was a 42.59 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,751 shares of company stock valued at $13,603,991. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

CI has been the topic of several analyst reports. Mizuho increased their target price on The Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Barclays lifted their target price on The Cigna Group from $339.00 to $382.00 and gave the company an "overweight" rating in a research note on Monday. Truist Financial increased their price target on The Cigna Group from $375.00 to $385.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. UBS Group cut their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. Finally, Guggenheim reaffirmed a "buy" rating and set a $388.00 price target (up from $384.00) on shares of The Cigna Group in a research note on Monday. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group has an average rating of "Buy" and a consensus target price of $378.22.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.